Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Freund

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Anticancer Research|June 6, 1998
Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapyX W Tong, D G Engehausen, R H Kaufman, et al.
JCI Insight|May 22, 2025
Unique characteristics of autoantibodies targeting MET in patients with breast and lung cancerMichal Navon, Noam Ben-Shalom, Maya Dadiani, et al.
BMC Biotechnology|January 15, 2013
ISA-TAB-Nano: a specification for sharing nanomaterial research data in spreadsheet-based formatDennis G Thomas, Sharon Gaheen, Stacey L Harper, et al.
Bioinformatics (Oxford, England)|April 1, 2011
The caBIG® Life Science Business Architecture ModelLauren Becnel Boyd, Scott P Hunicke-Smith, Grace A Stafford, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|July 2, 2011
Informatics and standards for nanomedicine technologyDennis G Thomas, Fred Klaessig, Stacey L Harper, et al.
Communications Biology|August 5, 2022
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodiesRuofan Li, Michael Mor, Bingting Ma, et al.
Cell Reports|April 24, 2026
Decoy antibodies block extracellular HSP70, prevent self-signaling, and inhibit melanoma cell survivalNoam Ben-Shalom, Shivang Parikh, Lilach Abramovitz, et al.
Scientific Reports|February 11, 2021
Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signatureAriel Munitz, L Edry-Botzer, M Itan, et al.
Brain, Behavior, and Immunity|June 27, 2023
β2-adrenergic signaling promotes higher-affinity B cells and antibodiesNoam Ben-Shalom, Elad Sandbank, Lilach Abramovitz, et al.
Nature Communications|February 25, 2016
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic miceAndrew T McGuire, Matthew D Gray, Pia Dosenovic, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Anticancer Research|June 6, 1998
Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapyX W Tong, D G Engehausen, R H Kaufman, et al.
JCI Insight|May 22, 2025
Unique characteristics of autoantibodies targeting MET in patients with breast and lung cancerMichal Navon, Noam Ben-Shalom, Maya Dadiani, et al.
BMC Biotechnology|January 15, 2013
ISA-TAB-Nano: a specification for sharing nanomaterial research data in spreadsheet-based formatDennis G Thomas, Sharon Gaheen, Stacey L Harper, et al.
Bioinformatics (Oxford, England)|April 1, 2011
The caBIG® Life Science Business Architecture ModelLauren Becnel Boyd, Scott P Hunicke-Smith, Grace A Stafford, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|July 2, 2011
Informatics and standards for nanomedicine technologyDennis G Thomas, Fred Klaessig, Stacey L Harper, et al.
Communications Biology|August 5, 2022
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodiesRuofan Li, Michael Mor, Bingting Ma, et al.
Cell Reports|April 24, 2026
Decoy antibodies block extracellular HSP70, prevent self-signaling, and inhibit melanoma cell survivalNoam Ben-Shalom, Shivang Parikh, Lilach Abramovitz, et al.
Scientific Reports|February 11, 2021
Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signatureAriel Munitz, L Edry-Botzer, M Itan, et al.
Brain, Behavior, and Immunity|June 27, 2023
β2-adrenergic signaling promotes higher-affinity B cells and antibodiesNoam Ben-Shalom, Elad Sandbank, Lilach Abramovitz, et al.
Nature Communications|February 25, 2016
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic miceAndrew T McGuire, Matthew D Gray, Pia Dosenovic, et al.
Pageof 8